313 related articles for article (PubMed ID: 30324779)
21. p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues.
Fan GK; Xu F; Yang B; Fujieda S
Acta Otolaryngol; 2006 Mar; 126(3):301-5. PubMed ID: 16618659
[TBL] [Abstract][Full Text] [Related]
22. Laryngoscopic characteristics related to the risk of cancerization of vocal cord leukoplakia.
Li LJ; Yu Z; Zhu JQ; Wang ML; Li ZX; Yang C; Ni XG
Acta Otolaryngol; 2021 Aug; 141(8):802-807. PubMed ID: 34314296
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic Aspects of Vocal Fold Leukoplakia in Smokers and Nonsmokers.
Rutt AL; Wang C; Li Z
J Voice; 2021 Sep; 35(5):779-784. PubMed ID: 32220397
[TBL] [Abstract][Full Text] [Related]
24. Elevated peripheral inflammatory markers are related with the recurrence and canceration of vocal fold leukoplakia.
Fang Y; Yang Y; Chen M; He P; Cheng L; Chen J; Wu H
Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2857-2864. PubMed ID: 31367834
[TBL] [Abstract][Full Text] [Related]
25. Phonosurgical resection using submucosal infusion technique for precancerous laryngeal leukoplakia.
Kono T; Saito K; Yabe H; Ogawa K
Laryngoscope; 2017 Jan; 127(1):153-158. PubMed ID: 27107249
[TBL] [Abstract][Full Text] [Related]
26. Significance of Cytokeratin-1 Single-Nucleotide Polymorphism and Protein Level in Susceptibility to Vocal Leukoplakia and Laryngeal Squamous Cell Carcinoma.
Yang Y; Zhou J; Wu H
ORL J Otorhinolaryngol Relat Spec; 2019; 81(2-3):121-129. PubMed ID: 31067553
[TBL] [Abstract][Full Text] [Related]
27. [Observation of clinicopathological characteristics of vocal fold leukoplakia and laryngopharyngeal reflux].
Zhu H; Xu W; Li Y; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 May; 49(5):368-73. PubMed ID: 25017219
[TBL] [Abstract][Full Text] [Related]
28. [The expression characteristics and clinical significance of candidate molecular markers in vocal cord leukoplakia].
Cui WX; Xu W; Yang QW; Li YR; Hu R; Cheng LY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):592-596. PubMed ID: 30121997
[No Abstract] [Full Text] [Related]
29. [Risk prediction and malignant transformation in vocal cord leukoplakia based on electronic laryngoscope].
Xu J; Li X; Wu J; Cun J; Ye F
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Oct; 35(10):901-904;909. PubMed ID: 34628812
[No Abstract] [Full Text] [Related]
30. Photodynamic therapy and the treatment of neoplastic diseases of the larynx.
Biel MA
Laryngoscope; 1994 Apr; 104(4):399-403. PubMed ID: 8164476
[TBL] [Abstract][Full Text] [Related]
31. [Management of T1a vocal fold carcinoma].
Reiter R; Brosch S; Smith E; Pickhard A
Laryngorhinootologie; 2013 Dec; 92(12):797-807. PubMed ID: 23929210
[TBL] [Abstract][Full Text] [Related]
32. [Coexistence in the same patient of different anatomical stages of cancer of the larynx].
Gaillard de Collogny L; Delage J
J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1967 Oct; 16(7):511-5. PubMed ID: 4233226
[No Abstract] [Full Text] [Related]
33. Relationship between laryngoscopic and pathological characteristics of vocal cords leukoplakia.
Zhang N; Cheng L; Chen M; Chen J; Yang Y; Xie M; Li C; Chen XL; Zhou L; Wu HT
Acta Otolaryngol; 2017 Nov; 137(11):1199-1203. PubMed ID: 28708442
[TBL] [Abstract][Full Text] [Related]
34. Vocal cord leukoplakia classification using deep learning models in white light and narrow band imaging endoscopy images.
You Z; Han B; Shi Z; Zhao M; Du S; Yan J; Liu H; Hei X; Ren X; Yan Y
Head Neck; 2023 Dec; 45(12):3129-3145. PubMed ID: 37837264
[TBL] [Abstract][Full Text] [Related]
35. [High concentrate A-mulsin, a new therapy concept in laryngeal leukoplakia].
Issing WJ; Struck R; Naumann A; Kastenbauer E
Laryngorhinootologie; 1996 Jan; 75(1):29-33. PubMed ID: 8851116
[TBL] [Abstract][Full Text] [Related]
36. Laryngeal dysplasia: Oncological outcomes in a large cohort of patients treated in a tertiary comprehensive cancer centre.
Chu F; De Santi S; Tagliabue M; De Benedetto L; Zorzi S; Pietrobon G; Herman I; Maffini F; Chiocca S; Corso F; Gandini S; Ansarin M
Am J Otolaryngol; 2021; 42(2):102861. PubMed ID: 33445041
[TBL] [Abstract][Full Text] [Related]
37. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
38. Classification of vocal fold leukoplakia by clinical scoring.
Fang TJ; Lin WN; Lee LY; Young CK; Lee LA; Chang KP; Liao CT; Li HY; Yen TC
Head Neck; 2016 Apr; 38 Suppl 1():E1998-2003. PubMed ID: 26849206
[TBL] [Abstract][Full Text] [Related]
39. Positive impact of retinyl palmitate in leukoplakia of the larynx.
Issing WJ; Struck R; Naumann A
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S105-9. PubMed ID: 9065641
[TBL] [Abstract][Full Text] [Related]
40. Histological and electron microscopic investigation of Reinke's edema.
Pastuszek P; Krecicki T; Zalesska-Krecicka M; Jeleń M; Rak J; Krajewska B
Pol J Pathol; 2003; 54(1):61-4. PubMed ID: 12817882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
